MCMVX | VMVAX | MCMVX / VMVAX | |
Total Expense Ratio | 0.85 | 0.07 | 1,214% |
Annual Report Gross Expense Ratio | 1.77 | 0.07 | 2,529% |
Fund Existence | 12 years | 14 years | - |
Gain YTD | -2.006 | -0.023 | 8,853% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 3000 | 167% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 34.5M | 29.9B | 0% |
Annual Yield % from dividends | 1.05 | 2.31 | 45% |
Returns for 1 year | 1.42 | 7.23 | 20% |
Returns for 3 years | 22.62 | 24.99 | 91% |
Returns for 5 years | 56.04 | 69.23 | 81% |
Returns for 10 years | 90.46 | 78.81 | 115% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSEPX | 65.64 | -0.86 | -1.29% |
Goldman Sachs US Equity Insights P | |||
FMCMX | 42.39 | -0.59 | -1.37% |
American Funds AMCAP 529-F-3 | |||
MDFGX | 37.56 | -0.54 | -1.42% |
BlackRock Capital Appreciation Inv A | |||
VCINX | 13.48 | -0.20 | -1.46% |
VALIC Company I International Growth | |||
NWHFX | 14.45 | -0.27 | -1.83% |
Nationwide Bailard Cogntv Val M |